Cancer Drugs and Vaccines

The main purpose of the drug is not only treating cancer, but also for relieving symptoms of the cancer such as pain and side-effects, such as nausea, commonly seen with the various types of treatment. Vaccines have been developed that prevent infection by some carcinogenic viruses. Human papillomavirus vaccine (Gardasil and Cervarix) decrease the risk of developing cervical cancer and helps in decresase in the risk of cancer. The hepatitis B vaccine prevents infection with hepatitis B virus and thus decreases the risk of liver cancer. The administration of human papillomavirus and hepatitis B vaccinations is advisable most commonly. Some cancer drugs are Cabazitaxel, Capecitabine, Carboplatin, and Cetuximab. Chemotherapy drug combinations are as such Cisplatin, Crizotinib. Most anti-cancer drugs act by inhibiting DNA synthesis in the cell growth cycle, because anti-cancer drugs generally affect rapidly dividing cells, other non-cancerous cells will also be affected. The site of the cells which is affected determines the side-effects of the individual drugs. Other cells affected include blood cells, which fight with the infection, helps in the blood clotting, and carry oxygen to all parts of the body. The movement the blood cells are affected, patients are more likely to get infected they may bleed very easily, and may feel weak and very tire. Rapidly dividing cells in hair roots, and cells that line the digestive tract, may also be affected.

The development of antibiotic resistance in particular stems from the drugs targeting only specific bacterial molecules. Because the drug is so specific, any mutation in these molecules will interfere with or negate its destructive effect, resulting in antibiotic resistance. Known as Drug delivery Conditions treated with combination therapy include tuberculosis, leprosy, cancer, malaria, and HIV/AIDS. One major benefit of combination therapies is that they reduce development of drug resistance, since a pathogen or tumor is less likely to have resistance to multiple drugs simultaneously. Artemisinin-based monotherapies for malaria are explicitly discouraged to avoid the problem of developing resistance to the newer treatment. Drug Induced Blood Disorders causes of sickle cell anemia,pale skin non steroids anti inflammatory drugs which causes ulcers Using drug repositioning, pharmaceutical companies have achieved a number successes, for example Pfizer's Viagra in erectile dysfunction and Celgene's thalidomide in severe erythema nodosum leprosum. Smaller companies, including Ore Pharmaceuticals, Biovista, Numedicus, Melior Discovery and SOM Biotech are also performing drug repositioning on a systematic basis. These companies use a combination of approaches including in silico biology and in vivo/in vitro experimentation to assess a compound and develop and confirm hypotheses concerning its usage for new indications.

  • Gene therapy
  • Vena Cava Filters
  • Surgery, Chemotherapy and Radiotherapy
  • Targeted therapy
  • Role of Translational Medicine

Related Conference of Cancer Drugs and Vaccines

June 29- July 1, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
July 27-28, 2017

4th International Conference and Exhibition on Medical Physics and Biophysics

Rome, Italy - Hotel Holiday Inn Rome
August 28-30, 2017

International Oncologist & Diagnostics Conference

Brussels, Belgium
September 18-19, 2017

International Conference on Cancer Biology and Drug Delivery

Philadelphia, Pennsylvania, USA
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany (H4 Hotel Frankfurt Messe)
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 16-17, 2017

World Cancer Meeting

Melbourne, Australia
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 23-24, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
March 14-16, 2018

Global Summit on Oncology & Cancer

Singapore
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan

Cancer Drugs and Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in